2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bedford, J. J. Articles by Walker, R. J. Search for Related Content PubMed PubMed Citation Articles by Bedford, J. J. Articles by Walker, R. J.

Aquaporin Expression in Normal Human Kidney and in Renal Disease

Jennifer J. Bedford^*, John P. Leader^* and Robert J. Walker

Departments of *Physiology and Medicine, University of Otago, Dunedin, New Zealand.

Correspondence to Prof. Robert J. Walker, Department of Medicine, University of Otago, P.O. Box 913, Dunedin, New Zealand. Phone: 64-3-474-0999; Fax: 64-3-474-7641;

ABSTRACT. Aquaporins (AQPs), membrane-inserted water channel proteins, play a highly important role in the reabsorption of water from the renal tubular fluid. Experimentally, both in rats and mice, failure to insert functional AQP molecules into renal tubular membranes leads to nephrogenic diabetes insipidus. In humans, most forms of renal disease lead to a reduction in the water handling capacity of the kidney. AQP distribution in various forms of human renal disease has not been documented. Immunohistochemical studies of biopsy samples from a wide range of renal diseases revealed a substantial and striking upregulation of AQP-1 in the glomeruli of most diseased kidneys. AQP-1 expression remained prominent in proximal tubules in all lesions. In contrast, there was judged qualitatively to be a reduction in the amounts of AQP-2 and AQP-3 expression, especially in lesions with substantial interstitial fibrosis and nephron loss, as compared with a healthy region of normal kidneys. The results were quantitatively confirmed by real-time reverse transcriptase–PCR. This is the first documentation of altered AQP expression in human renal disease. The significance of the increased AQP-1 expression requires further studies. E-mail: rob.walker@stonebow.otago.ac.nz

This article has been cited by other articles:

				E. J. Hoorn, M. G.H. Betjes, J. Weigel, and R. Zietse Hypernatraemia in critically ill patients: too little water and too much salt Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1562 - 1568. [Abstract] [Full Text] [PDF]

				J. J. Bedford, J. P. Leader, R. Jing, L. J. Walker, J. D. Klein, J. M. Sands, and R. J. Walker Amiloride restores renal medullary osmolytes in lithium-induced nephrogenic diabetes insipidus Am J Physiol Renal Physiol, April 1, 2008; 294(4): F812 - F820. [Abstract] [Full Text] [PDF]

				Y. E. Choi, S. K. Ahn, W. T. Lee, J. E. Lee, S. H. Park, B. B. Yoon, and K. A. Park Soybeans Ameliolate Diabetic Nephropathy in Rats Evid. Based Complement. Altern. Med., March 20, 2008; (2008) nen021v1. [Abstract] [Full Text] [PDF]

				G Giovannoni Neuromyelitis optica and anti-aquaporin-4 antibodies: widening the clinical phenotype J. Neurol. Neurosurg. Psychiatry, September 1, 2006; 77(9): 1001 - 1002. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673